| Period Ending | Mar 31, 2007 | Mar 31, 2005 | Dec 31, 2004 |
|---|
|
Total Revenue
|
1,827,000
|
1,675,000
|
1,783,000
| | Cost of Revenue | 840,000 | 1,610,000 | 1,499,000 | | |
Gross Profit
|
986,000
|
65,000
|
284,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 1,724,000 | 1,646,000 | 1,946,000 | | | |
Operating Income or Loss
|
103,000
|
29,000
|
(162,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 103,000 | 29,000 | (162,000) |
|
Interest Expense | (16,000) | (26,000) | (17,000) |
|
Income Before Tax |
-
|
-
|
-
|
|
Income Tax Expense | 3,000 |
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 88,000 | 5,000 | (224,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
51,000
|
5,000
|
(224,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
|
2.05%